Microgestin 1.5 / 30 is a birth control pill containing a combination of 2 female hormones: ethinyl estradiol and norethindrone.
- Uterine hypoplasia.
The drug oppresses the gonadotropic function of the pituitary gland, suppresses the development of the follicle and prevents ovulation. The contraceptive effect is enhanced by increasing the viscosity of cervical mucus and reducing the susceptibility of the endometrium to the blastocyst. The Pearl Index is 0.90. The frequency of pregnancy does not depend on such factors as age, race, and is increased in women with a body weight of more than 90 kg.
Each Microgestin 1.5 / 30 pack contains 21 active pills and 7 inert pills. Each active tablet contains 1.5 mg norethindrone acetate and 30 mcg ethinyl estradiol, each inert tablet contains 75 mg of ferrous fumarate.
Take 1 tablet daily for 28 days in a row. Menstrual bleeding occurs in the period of taking inactive tablets (22-28 tablets). When you use the drug for the first time or after a prolonged break or when switching from another contraceptive, the first tablet should be taken on the first day of the menstrual period. The drug should be taken at the same time of a day (to ensure a constant concentration of hormones in the plasma).
In the treatment of gynecological disorders, the dose Microgestin 1.5 / 30 is established in each case individually, depending on the indications.
Microgestin 1.5 / 30 can cause the following side effects:
- engorgement of the mammary glands;
- weight gain;
- changes in libido;
- mood reduction;
- eyelid edema;
- skin rash;
- visual impairment;
- hearing loss;
- generalized itching;
- intermenstrual bleeding;
Microgestin 1.5 / 30 is contraindicated in the following conditions:
- pregnancy and breastfeeding;
- hepatic insufficiency;
- congenital hyperbilirubinemia (Gilbert syndrome, Dubin-Johnson and Rotor syndrome);
- liver tumors (hemangioma, liver cancer);
- cerebral circulation disorders;
- ischemic heart disease;
- heart disease;
- diabetes mellitus;
- sickle cell anemia;
- breast and endometrial cancer;
- endometrial hyperplasia;
- fibroadenoma milk black fever;
- fat metabolism disorders;
- jaundice or pruritus during a previous pregnancy;
- age over 40.
With caution. diseases of the liver and gallbladder, epilepsy, depression, ulcerative colitis, uterine fibroids, mastopathy, chorea, tetany, porphyria, multiple sclerosis, varicose veins, tuberculosis, kidney disease, age under 18.
The birth control pill can interact with the following medications:
- barbiturates, carbamazepine, phenytoin
- ampicillin, rifampicin,
When taking Microgestin 1.5 / 30 contraceptives, it may be necessary to correct the dosage regimen for hypoglycemic drugs.
The contraceptive is contraindicated in pregnancy and breastfeeding.
If you miss an active tablet, take it within the next 12 hours. If a delay is more than 36 hours, a contraceptive effect cannot be guaranteed. It is recommended to use other non-hormonal birth control methods during this period.
If you miss an inert tablet, just throw it away and continue taking the drug according to the usual schedule.
The drug should be canceled immediately if you get pregnant, have migraine headaches, signs of phlebitis or phlebothrombosis (unusual pain or bloating of the veins on the legs), jaundice, visual impairment, cerebrovascular disorders, stitching pain of unclear etiology, pain and feelings of tightness in the chest, an increase in blood pressure. Stop taking the tablets 3 months before the planned pregnancy and 6 weeks before the planned operation.
Moderate spotting during the treatment does not require discontinuation of the birth control pills. If you have severe bleeding, consult a gynecologist.
If you have diarrhea or vomiting, a contraceptive effect of Microgestin 1.5 / 30 is reduced (you should use additional non-hormonal birth control methods).
Before taking the drug and every 6 months during treatment, you are recommended to undergo a general medical and gynecological examination (gynecological control, breast examination, liver function, blood pressure control, cholesterol concentration in the blood, urine analysis, cytological smear analysis).
Ethinyl estradiol and norethindrone can change the results of skin allergic tests and decrease the concentration of LH and FSH.
The efficiency of Microgestin 1.5 / 30 decreases with regular excessive intake of ethanol.
The use of the contraceptive after childbirth is recommended after the first normal menstrual period.
During the breastfeeding period, the release of milk may decrease.
Ethinyl estradiol and norethindrone are excreted in breast milk in small amounts.
Smoking women who take this hormonal contraceptive drug have an increased risk of developing vascular diseases with serious consequences. The risk increases with age and depends on the number of cigarettes smoked each day (especially in women over 30 years of age).